• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cdk5:神经退行性变的主要罪魁祸首。

Cdk5: A main culprit in neurodegeneration.

机构信息

Department of Bioinformatics, Alagappa University , Karaikudi , Tamilnadu , India.

出版信息

Int J Neurosci. 2019 Dec;129(12):1192-1197. doi: 10.1080/00207454.2019.1645142. Epub 2019 Sep 13.

DOI:10.1080/00207454.2019.1645142
PMID:31327290
Abstract

Neurodegenerative diseases (NDs) such as Alzheimer Diseases (AD), Parkinson Diseases (PD) are a huge public health problem. The elucidation of their pathophysiological mechanism is one of our greatest challenges. Hyperactive immune system contributes to the pathophysiology of neurological disorders. In this review article, we have highlighted the neurodegenerative role of CDK5 and its involvement in Amyloid precursor pathway via Beta secretase enzyme. All the landmark research reports for CDK5 were considered for this review and its involvement in disrupted autophagy and hyper immune response is the key cause for neurodegeneration. In conclusion, the present review focus on the pathways associated with Cdk5 and its role in causing neurodegeneration.

摘要

神经退行性疾病(NDs),如阿尔茨海默病(AD)、帕金森病(PD),是一个巨大的公共卫生问题。阐明其病理生理学机制是我们面临的最大挑战之一。过度活跃的免疫系统是导致神经紊乱的病理生理学原因之一。在这篇综述文章中,我们强调了 CDK5 的神经退行性作用及其通过β-分泌酶参与淀粉样前体途径。所有关于 CDK5 的重要研究报告都被纳入了本次综述,其对自噬和过度免疫反应的破坏是导致神经退行性变的关键原因。总之,本综述重点关注与 Cdk5 相关的途径及其导致神经退行性变的作用。

相似文献

1
Cdk5: A main culprit in neurodegeneration.Cdk5:神经退行性变的主要罪魁祸首。
Int J Neurosci. 2019 Dec;129(12):1192-1197. doi: 10.1080/00207454.2019.1645142. Epub 2019 Sep 13.
2
Cdk5: a multifaceted kinase in neurodegenerative diseases.Cdk5:神经退行性疾病中的多功能激酶。
Trends Cell Biol. 2012 Mar;22(3):169-75. doi: 10.1016/j.tcb.2011.11.003. Epub 2011 Dec 20.
3
Cyclin-dependent kinase 5--a neuronal killer?细胞周期蛋白依赖性激酶5——一种神经杀手?
Sci Aging Knowledge Environ. 2003 Dec 17;2003(50):pe36. doi: 10.1126/sageke.2003.50.pe36.
4
Silencing of CDK5 as potential therapy for Alzheimer's disease.沉默 CDK5 作为阿尔茨海默病的潜在治疗方法。
Rev Neurosci. 2011;22(2):143-52. doi: 10.1515/RNS.2011.015.
5
Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.在阿尔茨海默病转基因模型中,脑活素通过调节淀粉样蛋白前体成熟来减少β-淀粉样蛋白的产生。
J Neurosci Res. 2006 May 15;83(7):1252-61. doi: 10.1002/jnr.20818.
6
Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.Cdk5处于神经退行性疾病中蛋白质寡聚化的十字路口:事实与假说。
J Neurochem. 2016 Jan;136(2):222-33. doi: 10.1111/jnc.13365. Epub 2015 Oct 14.
7
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.源自细胞周期蛋白依赖性激酶5激活剂p35的肽,可特异性抑制细胞周期蛋白依赖性激酶5的失调活性。
Biotechnol J. 2007 Aug;2(8):978-87. doi: 10.1002/biot.200700057.
8
When good Cdk5 turns bad.当正常的Cdk5发生病变时。
Sci Aging Knowledge Environ. 2006 Feb 8;2006(5):pe5. doi: 10.1126/sageke.2006.5.pe5.
9
Cyclin-dependent kinase-5 in neurodegeneration.细胞周期蛋白依赖性激酶5与神经退行性变
J Neurochem. 2004 Mar;88(6):1313-26. doi: 10.1111/j.1471-4159.2003.02328.x.
10
Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.谷胱甘肽 S-转移酶 P1 是 Cdk5 激酶活性的关键调节因子。
J Neurochem. 2011 Sep;118(5):902-14. doi: 10.1111/j.1471-4159.2011.07343.x. Epub 2011 Jul 8.

引用本文的文献

1
Inhibition of CDK5 signaling mediated inflammation in macrophages promotes cutaneous wound healing.抑制巨噬细胞中CDK5信号介导的炎症可促进皮肤伤口愈合。
Sci Rep. 2025 May 27;15(1):18509. doi: 10.1038/s41598-025-02488-9.
2
Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的潜在酶及其治疗性抑制剂的最新进展。
Heliyon. 2024 Nov 28;10(23):e40756. doi: 10.1016/j.heliyon.2024.e40756. eCollection 2024 Dec 15.
3
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs.
揭示癌症和神经退行性疾病中的细胞周期失调及其相关机制:重新利用药物的一线曙光。
Mol Neurobiol. 2024 Nov;61(11):8600-8630. doi: 10.1007/s12035-024-04130-7. Epub 2024 Mar 26.
4
CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling.细胞周期蛋白依赖性激酶5通过E2F1信号通路促进胃癌细胞凋亡并减弱其化疗耐药性。
Cancer Cell Int. 2023 Nov 21;23(1):286. doi: 10.1186/s12935-023-03112-4.
5
Comprehensive analysis of CDK5 as a novel biomarker for progression in esophageal cancer.全面分析 CDK5 作为食管癌进展的新型生物标志物。
Esophagus. 2023 Jul;20(3):502-514. doi: 10.1007/s10388-023-00988-z. Epub 2023 Feb 28.
6
Differential expression of cyclins CCNB1 and CCNG1 is involved in the chondrocyte damage of kashin-beck disease.细胞周期蛋白CCNB1和CCNG1的差异表达与大骨节病软骨细胞损伤有关。
Front Genet. 2022 Dec 14;13:1053685. doi: 10.3389/fgene.2022.1053685. eCollection 2022.
7
Neurodegenerative Diseases: From Dysproteostasis, Altered Calcium Signalosome to Selective Neuronal Vulnerability to AAV-Mediated Gene Therapy.神经退行性疾病:从异常蛋白稳态、钙信号体改变到 AAV 介导的基因治疗对选择性神经元易损性。
Int J Mol Sci. 2022 Nov 16;23(22):14188. doi: 10.3390/ijms232214188.
8
Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.整合转录组分析确定预后关键基因作为胶质母细胞瘤的治疗靶点:基于生物信息学分析的证据
ACS Omega. 2022 Jun 22;7(26):22531-22550. doi: 10.1021/acsomega.2c01820. eCollection 2022 Jul 5.
9
Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson's disease.细胞周期蛋白依赖性激酶5磷酸化诱导的沉默调节蛋白2核转位促进帕金森病中多巴胺能神经元的死亡。
NPJ Parkinsons Dis. 2022 Apr 20;8(1):46. doi: 10.1038/s41531-022-00311-0.
10
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.当正常激酶失控时:糖原合成酶激酶3、p38丝裂原活化蛋白激酶和细胞周期蛋白依赖性激酶作为阿尔茨海默病和亨廷顿舞蹈症的治疗靶点
Int J Mol Sci. 2021 May 31;22(11):5911. doi: 10.3390/ijms22115911.